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Abstract
Hair loss and regeneration are the subjects of tremendous amount of research for mul-
tiple reasons: the well-known importance of hair in individual beauty, the fact that alo-
pecia is a frequent dermatological disease, and that there are limited treatment options. 
The present work focuses on the evaluation of animal models used for hair research and 
regeneration. Besides mentioning the option of in vitro studies, the chapter analyzes the 
need of an animal model of alopecia, common used study designs, hair regrowth evalu-
ation methods, and the limitations of the animal models in hair regrowth research. This 
chapter also discusses the structure of hair, its chemical composition, the properties and 
functions of hair, consequences of hair loss, the biology of hair loss, and regeneration and 
existing treatment options for alopecia. By using proper and well thought-out animal 
models, we aim to refine our knowledge on human hair diseases and hair regrowth. Hair 
research provides insights into the physiopathological pathways, genetic and cell bio-
chemical mechanisms, and remains a field intensively explored and still inexhaustible.
Keywords: animal models, research in vivo, hair regrowth, hair regeneration, alopecia
1. Introduction
Hair loss and regeneration is the subject of tremendous amount of research for multiple rea-
sons. First of all, as hair loss or alopecia is a frequent dermatological disease; second, the 
treatment options are limited and generate variable rates of success. Last but not least, hair is 
an important component of human outlook with a strong impact on the overall beauty and 
attraction of an individual. As several studies have shown, hair plays an interesting part in 
social and sexual communication.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the t rms of the Crea ive
Comm ns Attribution Lic nse (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The chapter addresses several issues: the importance of hair from both personal and social 
perspective, the structure and chemical composition of hair, hair functions and properties, 
biology of hair loss and hair regrowth, and consequences of hair loss and treatment options. 
The authors aim to offer an overview of the hair regrowth in vivo and in vitro studies, focusing 
on the animal models, and describing the common study designs and their limitations.
The main reason for hair research on animal models relies on the similarities between human 
and animal skin biology. New treatments for alopecia with different hair growth-promoting 
agents and various administration techniques have been tested on animal models to prove 
efficacy and to minimize possible adverse reactions.
2. Functions of hair
Also known as “fur” in animals, hair is a defining characteristic of mammals. Besides its 
important thermoregulatory function, it also has a camouflage purpose and offers protection. 
In animals, hair follicles can modify their type and density during seasonal coat changes [1]. 
It is noted that in some species, hair provides sensory and defensive functions, while in others 
it is used for signaling and communication [2, 3].
Although human hair has lost its main thermoregulatory function, on the scalp, it preserves a 
heat insulation and cooling purpose, by evaporating sweat from soaked hair [4–6]. It also acts 
as a sunscreen, offering the skin protection against ultra-violet radiation [7, 8].
3. Structure of hair
Hair is defined as an accessory structure of the integument along with the sebaceous glands, 
sweat glands, and nails [4]. The shaft of the hair (hard filamentous part that extends above the 
skin surface) consists of three layers, starting from the outside: the cuticle (having several layers 
of flat, thin cells, overlapping one another), the cortex (containing the keratin bundles in rod-
like cell structures), and the medulla (a disorganized and open area at the fiber’s center) [9, 10].
In the dermis, we find the bulb of the hair, which contains the dermal papilla. It has an important 
role in hair formation, growth, and hair cycle [11]. Besides maintaining stem cells that regrow the 
hair after it falls out, it also nourishes the hair follicle (providing nutrients and oxygen to epider-
mal cells in the lower layer) due to the blood vessels present at the bottom of the dermal papilla [1].
4. Chemical composition of hair
Hair has a complex chemical structure, containing organic substances (glycogen, acidic polysac-
charides, lipids and proteins—amino acids). About 90% of the hair structure consists of proteins, 
out of which keratin (a combination of 18 amino acids) is the essential component, being produced 
by the skin keratinocytes. The lipids represent 3% of the hair composition and are supplied by the 
sebaceous glands or produced in the hair bulb from sterols, fatty acids, and ceramides [12, 13].
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Hair also contains inorganic substances (carbon 45.2%, oxygen 28%, hydrogen 6.6%, nitrogen 
15%, and sulfur 5.2%) and water. Other mineral components of hair consist of iron, copper, 
calcium, magnesium, zinc, potassium, and lead, all of them of external sources.
5. Properties of hair
The color of hair depends on the type and quantity of melanin inside the cell. The hair follicle 
pigmentary unit provides the hair shaft color due to the melanin components (eumelanin and 
pheomelanin) and the interactions between follicular melanocytes, keratinocytes, and fibro-
blasts (also involved in wound healing) [11, 14]. In the case of the black hair, the pigment is 
also found in the extracellular compartment.
Hair is flexible and has elastic properties, being able to get longer by 20–50% under controlled 
traction. Under heat action, the elasticity decreases and hair can break easily. Hair is also 
hygroscopic, it can absorb water; a fact which decreases hair elasticity and resistance to a third 
of its normal value [4, 10].
Hair resistance is mostly due to cysteine amino acid, a substance rich in sulphur, which plays 
an important role in hair cohesion. Hair resistance seems to be increased to physical and 
biological agents and decreased to chemicals. Excessive light with UV exposure, repetitive 
hair-dye, and hair perm generate the alteration of the hair elastic properties by the chemical 
and photochemical degradation of the amino acids from the keratin structure. Hair resistance 
equals to a force of 60 kg, but it is decreased in children and elderly people. Hair resistance 
also depends on the hair diameter [4, 6].
6. Biology of the hair loss and hair regrowth
Human hair is different from hair grown by mammals due to unsynchronized growth cycles 
and a sensitive response to androgen.
Human hair exhibits a certain seasonal coordination, but the follicles work independently 
[15–17]. Latest research results sustain the idea that hair follicles act like neurons, being able 
to interconnect and generate hair loss and hair regrowth in a small region of the scalp. Human 
hair has a mosaic pattern as it consists of hair in different stages: the majority of the hair fol-
licles (90%) being in growing phase (also known as anagen), 1–2% in regression (catagen 
phase), and 8–9% of the hair follicles are resting (in telogen phase) [18, 19]. The cyclic changes 
from anagen to telogen via catagen involve rapid remodeling of both the epithelial and der-
mal components of hair follicles [20, 21].
In both humans and animals, hair cycle is influenced by stimulatory and inhibitory factors, 
such as hormones, growth factors, cytokines, neuropeptides, and pharmaceutical products 
[18, 22, 23]. The dermal papilla supports an increased cell division and growth rate and 
induces the shift between anagen, catagen, and telogen [18, 19]. In telogen phase, the old 
hair is lost, but the follicle will be regenerated in early anagen, when new hair grows up 
[24, 25].
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Current concepts of hair loss pathogenesis include genetic, genomic, hormonal, and immune 
contributions. Furthermore, the patient’s behavior influences the hair density and its strength. 
In recent years, evidence has suggested that hair loss is a multifactorial disease, and the con-
tributing factors include the resistance to insulin, local pathologies (inflammation, hypoxia, 
and vascular insufficiency), predisposing physiological factors (menopause and aging), asso-
ciation with other diseases (polycystic ovary syndrome, hirsutism, acne, hormonal imbal-
ances, thyroid pathologies, and other autoimmune diseases). Hair loss remains a consequence 
of the genotype (hereditary information of the organism)-phenotype (morphology, behavior, 
and development) interaction [25, 26].
The most common form of hair loss is known as “androgenetic alopecia” (AGA), which rep-
resents almost 95%. In this case, hair loss is generated by hair cycle abnormalities, such as the 
shortening of the anagen, within an abnormal hair cycle, and the anagen-telogen rate shifting 
from 6:1 to 2:1. Also, hair loss can be due to a small-sized dermal papilla. Both situations lead 
to shortening of hairs, decreasing hair diameter, shaft loss, and an increased number of hairs 
in telogen phase. In most situations, the changes of hair diameter (hair thinning) are followed 
by the loss of pigment: final hair (thick and pigmented) can turn back into vellus (thin and 
white). Studies point out that another cause of hair loss is the fact that the scalp suffers from 
vasoconstriction and hypoxia [27, 28].
Hair cycle disturbances are mainly caused by an excess of androgens, which alters the pro-
duction of regulatory factors (soluble paracrine factors and extracellular matrix components) 
by the dermal papilla cells [13]. Some specific sites of the body (beard, axillary, and pubic 
hair) react differently than hair from the scalp, as they are androgen-sensitive [4]. Hair min-
iaturization and thinning, followed by hair fall is most common in the vertex and the crown-
frontal area of the scalp [29, 30].
The occipital part of the scalp is an androgen insensitive area that is why in alopecia, hair is 
still present in this region, and hair follicles are suitable to be used in hair transplants [31, 
32]. The androgen effect on hair can be summarized by the metabolization of the testosterone 
into 5-alpha-dihydrotestosterone by 5-alpha reductase. A good metabolization limits the hair 
length (in case of the beard, for example) and deficiencies of the 5-alpha reductase generate 
enlarged hair diameter (thicker hair in the axillary and pubic area) [19, 33–35].
Another form of alopecia is Alopecia areata (AA), a cell-mediated disease directed against 
active growing hair follicles. It is a nonscarring alopecia, with limited alopecic patches on 
the scalp or the body, sometimes affecting also the nails. The pathogenesis of AA includes an 
autoimmune etiology, linked to human leukocyte antigen (HLA) class II alleles and to the T 
lymphocytic co-stimulatory cascade [30].
7. Genes associated with hair loss
Several studies including recent genome-wide association analyses concluded that a large 
number of single nucleotide polymorphisms (SNPs) are associated with AGA susceptibility. 
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So far, only some of the genes involved in hair loss have been discovered: genes AR androgen 
receptor and EDA2R ectodysplasin A2 receptor from chromosome X, region located at 20p1 
on chromosome 20, and additional loci associated with early onset baldness in Europeans, 
such as HDAC9 in 7p21.1, TARDBP (chr1), HDAC4 (chr2), AUTS2 (chr7), SETBP1 (chr18), q35 
(WNT10A), chr3q25 (SUCNR1), chr5q33.3 (EBF1), and chr12p12.1 (SSPN) [36].
8. Consequences of hair loss
Alopecia can be a part of the normal aging process. Still, hair loss represents a great concern 
for patients. Several studies have shown that it generates anxiety and distress especially in 
females, affecting couple and social relationships [37–39].
Hair loss is defined as a stressful experience for both sexes, patients being unable to cope with 
the progression of the disease [40, 41]. Stress functions not only as a cause, a risk factor, but 
also as a consequence of hair loss. Alopecia determines a poor quality of life by the physical 
and psychological sequelae: low self-esteem, depression, distorted social perception, and psy-
chosocial functioning [42–45].
9. Hair regrowth treatment
Up to the present, although many treatments have been tested, hair loss continues to be a 
frequent dermatological condition [46].
Two FDA-approved hair loss treatment drugs: Finasteride (acting on the hormonal cause of 
alopecia—the excess of androgens) and Minoxidil (acting on the physical cause—the hypoxia 
due to vasoconstriction), are commonly used in clinical practice in order to treat androgenetic 
alopecia, which represents 95% of all hair loss causes [38, 47–49]. Minoxidil (1 mg per day) is 
a topical formulation available in 2 and 5% concentration. It stops hair loss and promotes hair 
growth as it is a vasodilator and potassium channel opener, allowing more oxygen, blood, 
and nutrients to reach the follicle [50–53]. It has no therapeutic action on the hormonal and 
genetic causes of hair loss; therefore, it must be used as a continuous support for the hair 
follicles, otherwise the hair regrowth will cease and hair loss will begin again in 1–2 months 
[54–57]. Finasteride is a dihydrotestosterone-suppressing 5-alpha-reductase inhibitor, recom-
mended for male use only, decreasing the serum levels of dihydrotestosterone, stopping hair 
fall (in 48% of the cases), and stimulating hair regrowth (in 51% of the cases). Studies have 
shown that 1 mg of finasteride oral treatment has an efficacy similar to daily topical applica-
tion of minoxidil [58–60]. Given the temporary efficacy of finasteride and minoxidil and the 
limited number of treatments available in alopecia, new therapies are needed to prevent hair 
loss and enhance hair regrowth [61, 62].
Pharmaceutical hair loss management also includes different substances (arginine, aminexil, 
caffeine, and taurine), different peptides, B spectrum vitamins, zinc, or different procedures 
Evaluation of Animal Models Suitable for Hair Research and Regeneration
http://dx.doi.org/10.5772/intechopen.69698
239
(application of stem cells or plasma-rich platelets and low-level laser therapy), even if clinical 
studies in this respect are lacking. A large variety of over-the-counter products claim to treat 
hair loss pathology: hair tonics, hair balms, hair masks, shampoos, leave in conditioners, topi-
cal solutions, or foams function as potential anti-hair loss agents [43, 44, 63–68].
Alternatives to traditional treatment are laser (low-level laser therapy) and platelet-rich 
plasma (PRP) injections [47, 69].
10. Hair follicle regrowth using gene therapy
Gene therapy aims to deliver genetic material (DNA) into the patients’ cells with either a 
prevention or therapeutic purpose. The therapeutic effect could theoretically be obtained by 
replacing the mutant gene that causes the disease with a healthy gene, inactivating a mutated 
gene that causes an imbalance in the organism or introducing a new gene that could fight a 
particular disease. For the introduction of the gene, a carrier called vector is used, and it usu-
ally consists of a modified virus (retrovirus) that will not produce a disease in the organism, 
but will deliver the gene by integrating the genetic material into the chromosome of a particu-
lar cell. The delivery pathway may consist of a direct injection into the tissue or it can be given 
intravenously, to reach the blood flow [36].
As new evidence shows that 80% of the baldness is genetic, gene therapy could be the solu-
tion, although it encounters technical problems that have not been solved up to the present 
[69]. Most of the hair loss complains in both female and male patients are due to the presence 
of androgenetic alopecia, caused by hyperandrogenism and sensitivity to dihydrotestoster-
one (DHT). It has been noticed that people naturally lacking from birth the 5-alpha reductase 
enzyme (which converts the testosterone to DHT) never develop androgenetic alopecia [50].
Human scalp has DHT-resistant follicles in the occipital area, this location being used to 
extract the hair follicles for transplant into the vertex or to the fronto-parietal area [53]. Gene 
therapy may be a solution in this case, if it can trigger the hair follicles with DHT-sensitive cells 
and change them into DHT-resistant follicles that could regrow hair without being affected 
by androgen hormones [70]. Another option would consist of the ribonucleic acid (RNA) 
interference to block the genes responsible for hair loss. Messenger ribonucleic acid (mRNA) 
represents the carrier of genetic information from the DNA out of the cell nucleus into the 
cytoplasm, where it is translated into specific proteins, such as receptors, enzymes. Small frag-
ments of nucleic acids, such as small interfering RNAs (siRNAs), can target a specific gene and 
block the production of any type of protein in a cell. In hair loss, this technology could be used 
in order to inhibit the androgen receptor (AR) and the 5-alpha reductase enzymes.
Up to the present, an attempt to effectively control delivery of small interfering RNA using 
biodegradable cationized gelatin microspheres in an animal model of disease was first per-
formed in 2008. Researchers administered local injections of interleukin-4 and neutralizing 
anti-interferon-γ antibody in C3H/HeJ mice. They concluded that alopecia areata was effec-
tively treated as the treatment suppressed CD8 T cell infiltrates around the hair follicles and 
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repressed enhanced interferon-γ mRNA expression in alopecic skin. Also, restoration of hair 
shaft elongation occurred due to Th1 transcription factor T-box 21 small interfering RNAs 
conjugated to cationized gelatin [71]. Another recent study showed that the sonic hedgehog 
(shh) gene stimulated the hair shaft production and anagen phase in C57BL/6 mice, after being 
delivered with an adenovirus vector [72].
Gene therapy is currently available only in research settings. It represents a promising thera-
peutic option for several diseases (especially those with no cure for the moment), but this 
procedure needs more research and improvement that need to be considered safe and to 
prove its effectiveness. So far, scientists have encountered difficulties in finding proper deliv-
ery pathways of the genes to the body, targeting them to particular cells, controlling the new 
gene(s) and their effect after they have been inserted into the body [73].
11. Hair regrowth studies in vitro
Human hair follicles as research material for hair loss and regeneration involve ethical prob-
lems, an invasive collection method and a limited quantity of follicles available for extraction 
and testing [60, 61].
The first methods of isolation and maintenance of hair follicles in cell cultures go back to 1990, 
when several researchers used this method in order to study the biology of the hair cycle [74, 
75]. Follicles were usually taken during face lifting surgery, but only a third were suitable 
for the isolation phase of the hair transplant, due to improper collection procedures. The fol-
licles needed to be isolated from human scalp in a few hours, maintained at 2–6°C, in an Earl 
medium, combined with phosphate buffered saline solution, with calcium and magnesium 
added. Only the follicles that seemed intact were used.
In vitro hair research was supported by the identification of growth factor function in the pro-
cess of hair regrowth and differentiation [76–79]. Philpott et al. have reported that in the absence 
of insulin, follicles prematurely enter the catagen stage [80]. Subsequent in vitro and in vivo 
studies, in murine and human models of hair follicles, have demonstrated that IGF-1 level is a 
regulation factor of hair growth and together with IGF-1 receptor influence hair growth cycle.
Other studies performed in 1990 have shown that transforming growth factor beta 2 (TGF-ß2) 
promotes anagen to catagen transition. Several inhibitors of hair follicle growth in vitro have 
been identified such as interleukins (IL-1 alpha and beta) and tumor necrosis factor (TNF-alpha). 
Researchers concluded that these cytokines play a significant part in the pathophysiology of hair 
inflammatory diseases. Although the factors that perform the transition in vitro from anagen to 
catagen have been discovered, inducing a full hair growth cycle has not been made possible yet. 
Murine models of hair follicles, isolated at different growth stages in vitro seem to maintain their 
cyclic activity and to illustrate their status in vivo [81].
On the other hand, healthy human dermal papilla cells, isolated from hair follicle, lose the 
ability to produce hair growth when being outside the body. Also, cycling hair follicles cannot 
be maintained in culture for any length of time [82].
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The data that we now possess about the life and function of the hair follicle in health and 
disease rely on the successful research performed in vivo (experiments on natural animals and 
genetically manipulated models) and in vitro (cultures of a cell type—dermal papilla or organ 
culture of isolated cell follicles). The preference for one of the two experimental alternatives 
depends on several factors: the purpose of the research and the advantages and disadvan-
tages involved.
12. Hair regrowth studies in vivo
12.1. The need of animal models
Animals and humans are remarkably similar at physiological and anatomical levels. Also, 
genetically speaking, we share 67% of our DNA with earthworms and 99% with mice. Almost 
90% of the veterinary medicines used to treat animals are similar to the ones developed for 
human use. Animal models can mimic human responses, but the differences in species and 
even in individual animals must be taken into consideration [83]. By recreating human dis-
eases in animal models, we can study and understand the physiopathological processes 
involved in the disease and maybe find an efficient cure. The first Nobel Prize was awarded in 
1901 and other 94 prizes were directly dependent on animal research [84].
Laboratory animals are used when human testing is not available for practical or ethical rea-
sons. Animals represent good research subjects as they have a shorter life cycle that enables 
scientists to observe the animal throughout the entire life and across several generations. 
Also, animal models can be easily influenced by the environment, which is controlled by the 
researcher as far as the diet, temperature, lighting, and other factors are concerned.
Researchers use animal models for short-term objectives (to determine how the animal model 
responds to a stimuli or a treatment) and long-term purposes (development of a new drug, 
evaluation of bioavailability or toxicity, genetic study). The animal model should be sensitive, 
appropriate for the studied condition either by using specific evidence of previous studies 
or using a new animal model with the risk of generating inaccurate results [69]. Besides the 
similarity with the human response, other key features of the biomedical research on animal 
models are specificity to the study purpose, validation of the animal model, and improvement 
for further research. Animal research has brought many benefits not only to humans but also 
to animals in disease prevention and treatment [47, 48, 69].
For more than a 100 years, almost all the information obtained in the human and animal 
health research has been the result of studies performed on animal models. The most common 
aim of animal models use is the development of new methods for the diagnosis and treatment 
of diseases, through an understanding of the biology and the physiopathological processes 
involved [47, 69].
Even though animal models remain a necessity, alternatives consist of computer models, tis-
sue and cell cultures, and other nonanimal-related research methods. In order to minimize the 
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harmful effect of research performed on animal models, scientists tend to reduce the number 
of animals used to obtain valid results, to refine the experimental technique, or replace it with 
nonanimal research methods.
12.2. Animal models used in hair loss and regrowth
A large variety of animals (mice, rats, hamsters, rabbits, sheep, and even stump-tailed 
macaque) provide useful models for the in vivo study of hair loss and regrowth, but 95% of 
the animals bred for research purposes are rats and mice [85–89].
Mice represent an excellent model to study the hair cycle for several reasons: the first two 
cycles of the mouse hair follicle are synchronized; the mouse hair cycle is short, lasting for 3 
weeks; hair follicles can be easily harvested and examined at specific time points in the cycle. 
Most importantly, the stages of the hair cycle have been well characterized in the mouse: 
anagen being morphologically subdivided into six stages and catagen into eight [22]. The 
periodic intervals of rodent hair cycles (especially the anagen-growing phase) seem to be 
less susceptible to iatrogenic influences [90]. The mouse hair cycle does not differ structur-
ally from the human hair follicle cycle, except for the fact that during catagen the hair bulb is 
remodeled, but the vibrissae follicles do not retract. Scientists have recently discovered that 
a certain progenitor cell population in mice is analogous to the human cells, encouraging 
research on this particular animal model.
Besides studying the normal hair cycle on mice, scientists also focussed on the growth waves 
and hormonal control [91]. Significant differences between species regarding the follicular 
function and limited androgen-sensitive models were noticed [92]. Spontaneous mutations 
have been discovered and studied on hairless, nude, and tabby mutants, waved and angora 
animals, leading to the identification of new genes involved in hair loss and opening the path 
for transgenic technology research [93, 94].
Transgenic mice, also known as “knockout mice,” are mice with altered genome through the 
use of genetic engineering. This gene-targeting technique has revolutionized the biomedical 
research by offering researchers the ability to create a specific animal model for the most com-
mon human diseases. In order to select the most appropriate immunodeficient mouse models 
for research purpose, scientists also take into consideration: background strain, behavior, hus-
bandry, disease susceptibility, life span, breeding performance, radiosensitivity, functional-
ity of various endogenous immune system components, and leakiness (tendency to produce 
functional B and T cells as they age).
Up to the present, immunodeficient mice (with T and B cells deficiencies) were used as mod-
els for autoimmune disease mechanisms and androgenetic alopecia studies. The androgen 
action upon the hair follicles has been studied on spontaneous and genetically engineered 
nude mutant mice [95].
The C57BL/6 mouse is the most popular laboratory rodent, widely used and studied, having 
its entire genome published. Research applications using this particular type of mice include 
immunology, cancer, neurodegerative disease, age-related hearing loss, bone density, diabetes, 
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obesity, and biomarker studies. This black coat mouse has been used for the skin-free pig-
ment and early visible pigmented tips of new anagen regrowth [88]. C57BL/6 represents one 
of the most well-characterized models available, with a minimum risk of genetic drift. It is 
also a convenient model for creating transgenic mice, which are recognized by the mixed coat 
colors.
The C3H/HeJ mouse model was used in a large range of studies: immunology, cancer (espe-
cially mammary tumors), inflammation, sensorineural, and cardiovascular disease. This ani-
mal model was the most widely reported for hair growth promotion, most possibly due to the 
fact that C3H/HeJ mice can spontaneously develop alopecia areata (AA) from 6 to 18 months 
of age. Also, alopecia areata can be surgically induced by skin-grafting from a donor animal 
with AA onto an isogenic C3H/HeJ recipient (normal haired mice of the same strain) [90, 96].
In 2010, researchers created the first rodent model of AGA, taking into consideration its 
relationship to androgen metabolism and androgen signaling, mediated by the androgen 
receptor (AR). They used transgenic mice overexpressing human AR in the skin under con-
trol of the keratin 5 promoter and exposed them to high levels of 5-alpha dihydrotestos-
terone, which led to delayed hair regeneration, mimicking AGA. The scientists concluded 
that androgen-mediated hair loss is AR-dependent and suggested that AR and beta-catenin 
mediate this effect [97].
There are many rat strains raised for research purposes, but the albino Wistar Bratislava rat 
is the most commonly used. Gene knockout techniques are relatively difficult to be applied 
and successfully achieved in rats. For hair loss and regeneration experiments, the Wistar rats 
and the Dundee Experimental Bald Rat (DEBR) strain were commonly used. The latter has the 
ability to spontaneously develop adult onset alopecia areata (AA) at a higher frequency than 
in the mouse model [98].
In the research field of hair loss and regeneration two major achievements must be mentioned 
on the rat animal model: coaxing human stem cells to become dermal papilla and producing 
new hair follicles when transplanted on rat skin [98]. Also, by inhibiting the rejection of for-
eign skin, human skin grafts were applied and even rat dermal papillae continued to produce 
hair after reimplantation in vivo on a rat model [99, 100].
Research performed on a rabbit animal model, added important data to the field, proving that 
full thickness transplants, made with full pedicle graft (separated from their original nervous 
and vascular supply) retain their original intrinsec activity and are not modified by the action 
of the surrounding tissue [101]. Furthermore, the rabbit represents a common animal model 
used to screen compounds potentially efficient in treating alopecia.
The Golden Syrian hamster (Mesocricetus auratus) has been previously used for research pur-
poses, even though it is a very common pet. The hamster flank organ has served as a model 
to study the effect of testosterone (T) upon the hair follicle, the sebaceous glands, and the 
dermal pigment. This hamster is known to be useful for the specific and quantitative assess-
ment of different substances on hair growth, being also useful for therapy testing in hirsutism. 
Macroscopic (hair density evaluation) and microscopic (hair diameter analysis) hair growth 
assessments have been performed on Golden hamsters [102].
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12.3. Common study designs in hair loss and regrowth
12.3.1. Housing conditions
In vivo hair regrowth studies usually use animals of either sex and weight, kept in experi-
mental rooms that are free of pathogens and opportunistic agents. For 7–14 days prior to the 
experiment, the animals are housed under specific conditions: room temperature of 23°C, 
controlled humidity, a 12:12 h light, and dark cycle. In order to avoid licking, individual hous-
ing is preferred or a maximum of two animals per cage. Standard laboratory diet and water 
ad libitum are provided. After completing the experiment, animals are euthanized according 
to the current regulations. For accurate results, most of the studies on animal models are per-
formed in triplicate [47, 69].
12.3.2. Depilation methods
Experimental designs may include one of the depilation methods: shaving, the use of a raisin 
mixture, or a hair removal cream [91, 103]. The most commonly used is the shaving of a larger 
skin area (the whole back or body) or of several smaller areas that are denuded for testing. 
For animal immobilization during procedures, general anesthesia is commonly performed 
with a combination of ketamine (i.p. 50 mg/kg b.w.) and xylazine (20 mg/kg b.w.) [47, 48, 69].
Some study designs, such as that of Mester et al., required before each successive hair treat-
ment, the shaving of the skin. This procedure can induce mechanic stimulation of hair growth, 
as previously reported in the literature, and influence the study results. Other experiments 
done on adult rats point out that after the fur was dyed and shaved, the regrowing hairs 
formed a system of linear loops that were closely correlated with the shaving process [66, 67].
In order to avoid this effect, it is recommended not to shave the skin of the animal model 
before each session of therapy. Other factors which influence the hair regrowth are physical 
factors such as low temperature, which triggers fast regrowth after shaving.
Depilation-induced hair cycle has been studied, and it follows a strict course: nine days after 
depilation, the hair follicles enter the final stage of the growth cycle (anagen VI). On day 17 
after depilation, the follicles enter the regression stage (catagen), while on day 20 follicles get 
to the resting stage (telogen) [22].
12.3.3. Evaluation of hair loss and hair regrowth
Efficacy of the treatment is screened by observing the presence, rate, and cosmetic acceptabil-
ity of hair regrowth. More sophisticated assays include determining how the drug induced 
hair regrowth and exploring the pathogenesis of AA.
Researchers do not possess standardized methods for in vivo hair regrowth assessment. New, 
accurate, and minimally invasive procedures are still needed as the most commonly used 
tools are qualitative assessments, limited in number. They include macroscopic assessment 
with the naked eye (visualization and photographs of the area of interest) based on scales that 
assess the percentage of hair regrowth on the interest area and tricoscopic evaluation (with a 
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hand-held dermatoscope, with polarized light and magnification abilities) [41]. Trichoscopy 
allows a correct hair regrowth evaluation, as it can detect decrease of hair diameter up to ten 
times or diameter variations. Both macroscopic and microscopic methods assess hair regrowth 
with the help of personalized hair growth scales or standardized, already published scales.
Usually, the dorsal part of the animals is used for the testing. After being depilated and 
treated, the animal skin is observed and photographed at specific time intervals (day 1, 7, 
14, and 21) to record the start of the hair regrowth period and the pattern of hair regrowth, 
compared to controls. Several hair regrowth potential scores are mentioned by literature. The 
one described by Matsuda et al., for instance, ranges from 0 to 5: 0 = no hair growth, 1 = less 
than 20% of hair growth, 2 = 20–39% of hair growth, 3 = 40–59% of hair regrowth, 4 = 60–79% 
of hair regrowth, 5 = 80–100% of hair regrowth [54]. Researchers also use self-designed scales 
of hair regrowth that consider: Type IV (high hair density, full, thick fur), Type III (moderate 
hair density with no visible skin area), Type II (low hair density, with the visualization of the 
skin), Type I (uneven hair growth on the test area, skin easily seen) [47, 69].
The hair regrowth potential scores can be applied for both macroscopic and microscopic 
assessments (Figures 1 and 2).
On the other hand, quantitative methods, such as hair weight determinations, hair density 
measurements, or histopathological examination offer more accurate results. For hair weight 
determination, the regrown hair from an area of 1 cm2 of skin is cut and weighed with an 
analytical balance [48].
In order to analyze the histological features at the end of the treatment period, the animals are 
sacrificed and a skin biopsy is isolated for histopathological examination. The thickness of the 
skin and the location of hair follicles in the dermis can be assessed by microscopic photography.
Also the hair cycle can be assessed, as the anagen induction can be calculated with the for-
mula: (number of follicles in hypodermis) × 100/(number of follicles in dermis). Literature 
data showed an association of increasing skin thickness, follicle count, and macroscopic 
development of skin pigmentation with anagen induction [18, 23]. The study by Liu et al. 
found that in the anagen phase the bulb of the hair follicles was enlarged and deeply inserted 
into the dermis. The research also revealed that the hair follicles in the shaved, bare areas were 
short, small, and in the phases of telogen, anagen, or catagen [69].
Figure 1. Classification of the hair regrowth effect (type I, type II, type III, type IV) for macroscopic and microscopic 
assessments—personal study performed on Wistar Bratislava rats. The control area is marked with red (left side of the 
picture), the test area with blue (right side).
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The hair growth cycle, consisting of three phases (anagen, catagen, and telogen) is used by 
both practitioners and researchers to diagnose the hair growth condition and to decide on the 
hair growth-promoting agent. In human subjects, digital trichoscopy is available, with auto-
matic assessment of the number of follicles in each hair growth phase.
Several studies focused on the validation of Minoxidil 2% treatment on the animal model 
used, as this topical treatment is thought to be the gold standard treatment for hair loss. This 
substance affected the normal hair cycle by shortening telogen, causing premature entry of 
the resting follicles into anagen phase [103, 104].
12.4. Limitations of animal models regarding hair regrowth
The limitation of using an animal model while studying hair regeneration can be briefly sum-
marized as follows. First, synchronized hair cycles generate waves of new hair regrowth, 
which make the interpretation of result a hard task. Second, the lack of independence of the 
hair follicles, since they have coordinated regrowth pattern on a precise time scale, as described 
by Muller-Rover et al. [22]. Third, young mice present the drawback of patchy growth after 
the second wave of hair growth is completed. Lastly, the increased hair density on an animal 
model leads to difficulties of assessment by densitometry or cross-section trichometer [69].
The results of our hair growth research performed on Wistar rats showed, besides a normal 
hair growth in the majority of the animal models, a lack of hair regrowth on the tested area. 
Other studies performed on black-and-white mice reported that no further hair growth was 
observed on half of the control animals.
We also noticed a diffuse hair regrowth in some study groups, while in others, the hair 
appeared to make some specific linear loops that were observed macroscopically. Literature 
date confirmed our findings. In similar situations, researchers experienced a diffuse hair 
growth in some animals with an uncharacteristic, diagonal strip [66]. Li-Yaun Liu et al. 
described four main linear hair regrowth patterns noticed on a rat model: the dorsal loop and 
the lateral dorsal loop (running along the dorsum and hind limb) and the ventral loop and 
lateral ventral loop (traveling along the thorax, abdomen, and forelimb). These hair-loop-lines 
create cranio-caudally-oriented waves of regrowth 2–15 mm wide, symmetrically on both 
sides of the body, running from the head through the torso to the limbs [105]. Li-Yaun Liu 
et al. concluded that after shaving the skin, the hair follicles from these new hair lines were 
always in an anagen phase [106].
Figure 2. Classification of the hair regrowth effect (type 0, type 1, type 2, type 3, type 4, type 5) for macroscopic and 
microscopic assessments—personal study performed on New Zealand Rabbits.
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Also, the behavior of the animals should be taken into consideration, as it can create issues 
and interfere with the research results [107]. For example, the C57BL/6 mice show barber-
ing behavior, the dominant mouse in a cage selectively removing hair from its subordinate 
cage mates. Mice that have been barbered have large bald patches on their bodies, especially 
around the head, snout, and shoulders [108].
Regardless of the shortcomings of either animal model, most of them validate their usefulness 
for drug efficacy and safety testing for humans.
13. Conclusion
Although the studies performed on animal models encounter both technical and objective 
issues, further scientific research is not impeded and continues to remain an intensively 
explored field. By using proper and well-thought out animal models, we aim to refine our 
knowledge on human hair diseases and hair regrowth. Hair research provides further 
insights into the physiopathological pathways and genetic and cell biochemical mechanisms 
that could promise the cure of hair loss.
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